drugset / Trial / NCT00003249

Carboxyamidotriazole and Ketoconazole in Treating Patients With Advanced Cancers

NCT00003249

Phase 1 Completed 30 enrolled National Cancer Institute (NCI)
NaSingle-groupOpen-labelTreatment

Summary

Phase I trial to study the effectiveness of carboxyamidotriazole and ketoconazole in treating patients with advanced cancers. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.

Timeline

Start
1998-05
Primary completion
2001-12
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketoconazole Small molecule Oral
Subject carboxyamidotriazole Other / unclassified Oral